Riverhead Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Riverhead Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$238K	Buy	5,837 +200	+4%	+$8.63K	0.01%	1059
2019 Q2	$271K	Buy	5,637 +700	+14%	+$36.8K	0.01%	1012
2019 Q1	$309K	Buy	4,937 +100	+2%	+$6.87K	0.01%	932
2018 Q4	$289K	Buy	4,837 +200	+4%	+$12K	0.01%	900
2018 Q3	$299K	Buy	4,637 +1,000	+27%	+$55.8K	0.01%	1007
2018 Q2	$164K	Hold	3,637	–	–	0.01%	1187
2018 Q1	$113K	Hold	3,637	–	–	﹤0.01%	1297
2017 Q4	$109K	Buy	3,637 +800	+28%	+$23.2K	﹤0.01%	1314
2017 Q3	$94K	Buy	2,837 +406	+17%	+$14.1K	﹤0.01%	1295
2017 Q2	$81K	Buy	2,431 +1,031	+74%	+$30.8K	﹤0.01%	1294
2017 Q1	$41K	Buy	+1,400	New	+$34.7K	﹤0.01%	1316

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Riverhead Capital Management's BEAT Position: Q3 2019 in Review

Riverhead Capital Management increased its BioTelemetry, Inc. (BEAT) stake by 3.5% in Q3 2019, buying an estimated $8.63K and bringing the position to 5,837 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #1059.

Riverhead Capital Management first reported a position in BEAT in Q1 2017 and has held it in 11 quarters since. The position peaked at $309K in Q1 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

Riverhead Capital Management held 5,837 shares of BioTelemetry, Inc. worth $238K as of Q3 2019.
Riverhead Capital Management bought 200 BioTelemetry, Inc. shares in Q3 2019, an estimated $8.63K.
BioTelemetry, Inc. made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1059 holding.
Riverhead Capital Management first reported a position in BioTelemetry, Inc. in Q1 2017 and has held it in 11 quarters since.
Riverhead Capital Management's BioTelemetry, Inc. position peaked at $309K in Q1 2019.
219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.